Control-IQ+ Technology for Automated Insulin Delivery - Tandem Diabetes Proven results with Tandem Diabetes Care automated insulin delivery systems Control-IQ+ technology includes optional activity settings that adjust the range of treatment values Uses a narrower and lower range of treatment values to help guard against lows and highs while sleeping
Enhanced diabetes management: new Control-IQ+ Technology from Tandem . . . Control-IQ+ showcases an advancement in Tandem AID systems This new algorithm is designed to predict and help prevent both hyperglycemia and hypoglycemia, ensuring that users maintain optimal glucose levels throughout the day and night
Tandem Turns Up the Tech for t:slim X2 and Mobi Diabetes healthcare professionals can also help existing Tandem insulin pump users update their software to the new Control IQ+ algorithm Individuals living with diabetes depend on your expertise to guide them through the maze of diabetes technology
FDA clears Tandem Diabetes Care’s Control-IQ+ for type 2 diabetes Tandem's Control-IQ+ technology, now FDA-approved for type 2 diabetes, automates insulin delivery using continuous glucose monitoring data The technology will be available in the U S by March 2025, expanding options for adults with type 2 diabetes